These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Thalidomide for graft-versus-host disease after bone marrow transplantation. Saurat JH; Camenzind M; Helg C; Chapuis B Lancet; 1988 Feb; 1(8581):359. PubMed ID: 2893167 [No Abstract] [Full Text] [Related]
3. Thalidomide for the therapy of graft-versus-host disease following allogeneic bone marrow transplantation. McCarthy DM; Kanfer EJ; Barrett AJ Biomed Pharmacother; 1989; 43(9):693-7. PubMed ID: 2696566 [TBL] [Abstract][Full Text] [Related]
4. Thalidomide for graft-versus-host disease. McCarthy DM; Kanfer E; Taylor J; Barrett AJ Lancet; 1988 Nov; 2(8620):1135. PubMed ID: 2903342 [No Abstract] [Full Text] [Related]
5. Thalidomide for severe acute graft-versus-host disease. Ringdén O; Aschan J; Westerberg L Lancet; 1988 Sep; 2(8610):568. PubMed ID: 2900947 [No Abstract] [Full Text] [Related]
6. Thalidomide in the treatment of graft-versus-host disease. Heney D; Bailey CC; Lewis IJ Biomed Pharmacother; 1990; 44(4):199-204. PubMed ID: 2204450 [TBL] [Abstract][Full Text] [Related]
7. The role of thalidomide in the treatment of refractory chronic graft-versus-host disease following bone marrow transplantation in children. Rovelli A; Arrigo C; Nesi F; Balduzzi A; Nicolini B; Locasciulli A; Vassallo E; Miniero R; Uderzo C Bone Marrow Transplant; 1998 Mar; 21(6):577-81. PubMed ID: 9543061 [TBL] [Abstract][Full Text] [Related]
8. [Sclerodermatous cutaneous reaction of graft vs host disease treated with thalidomide]. Pédailles S; Troussard X; Launay V; Bazin A; Sentias C; Surbled M Presse Med; 1993 Jan 2-16; 22(1):37. PubMed ID: 8469665 [No Abstract] [Full Text] [Related]
9. Failure of thalidomide to control bronchiolitis obliterans post bone marrow transplant. Heaton DC Bone Marrow Transplant; 1989 Sep; 4(5):598. PubMed ID: 2790340 [No Abstract] [Full Text] [Related]
10. The use of thalidomide in chronic refractory graft versus host disease. van de Poel MH; Pasman PC; Schouten HC Neth J Med; 2001 Aug; 59(2):45-9. PubMed ID: 11476911 [TBL] [Abstract][Full Text] [Related]
11. Thalidomide as therapy for intestinal chronic GVHD. Lopez J; Ulibarrena C; Garcia-Laraña J; Odriozola J; Pérez de Oteyza J; Sastre JL; Navarro JL Bone Marrow Transplant; 1993 Mar; 11(3):251-2. PubMed ID: 8467293 [No Abstract] [Full Text] [Related]
12. Thalidomide in the management of chronic graft-versus-host disease in children following bone marrow transplantation. Cole CH; Rogers PC; Pritchard S; Phillips G; Chan KW Bone Marrow Transplant; 1994 Dec; 14(6):937-42. PubMed ID: 7711671 [TBL] [Abstract][Full Text] [Related]
13. Thalidomide for treatment of graft-versus-host disease. Vogelsang GB; Hess AD; Santos GW Bone Marrow Transplant; 1988 Sep; 3(5):393-8. PubMed ID: 3056547 [TBL] [Abstract][Full Text] [Related]
14. Use of thalidomide for CGVHD defended. Altomonte V Oncol Nurs Forum; 1993 Apr; 20(3):428. PubMed ID: 8497414 [No Abstract] [Full Text] [Related]
15. Chronic graft-versus-host disease revealed by lichenoid vulvar lesions successfully treated with thalidomide. Staumont-Sallé D; Magro L; Piette F; Thomas P; Jouet JP; Catteau B Acta Derm Venereol; 2003; 83(4):302-3. PubMed ID: 12926809 [No Abstract] [Full Text] [Related]
16. Thalidomide back in good graces--seems to help GVHD patients. Oncology (Williston Park); 1988 Sep; 2(9):29. PubMed ID: 3275064 [No Abstract] [Full Text] [Related]
17. Severe cutaneous ulceration following treatment with thalidomide for GVHD. Schlossberg H; Klumpp T; Sabol P; Herman J; Mangan K Bone Marrow Transplant; 2001 Jan; 27(2):229-30. PubMed ID: 11281398 [TBL] [Abstract][Full Text] [Related]
18. Quest to improve marrow transplant success yields new approaches to graft-vs-host disease. Kirn TF JAMA; 1987 Sep; 258(11):1438-9. PubMed ID: 3306001 [No Abstract] [Full Text] [Related]
19. Thalidomide in children undergoing bone marrow transplantation: series at a single institution and review of the literature. Mehta P; Kedar A; Graham-Pole J; Skoda-Smith S; Wingard JR Pediatrics; 1999 Apr; 103(4):e44. PubMed ID: 10103336 [TBL] [Abstract][Full Text] [Related]